Abstract B025: An agentic platform for designing cancer immunotherapies: From automated variant interpretation to in silico therapeutic validation
By CrisPRO Research|May 21, 2026
F Kiani, R Nayeem 路 Cancer Immunology Research 13 (9_Supplement), B025-B025, 2025
Abstract B025: An agentic platform for designing cancer immunotherapies: From automated variant interpretation to in silico therapeutic validation
CrisPRO presents an agentic workflow that connects variant interpretation, therapeutic hypothesis generation, and in silico validation for cancer immunotherapy design. The platform automates evidence synthesis across genomic and pathway layers.
F Kiani, R Nayeem
Cancer Immunology Research 13 (9_Supplement), B025-B025, 2025
Published abstract: https://aacrjournals.org/cancerimmunolres/article/13/9_Supplement/B025/765414/Abstract-B025-An-agentic-platform-for-designing
Categories
Conference Abstracts